Avaa skanneri

Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Kentän tynkä analyysia varten

Abbott Laboratories

ABT
Nykyinen hinta
104.59 USD +0.41 USD (+0.39%)
Viimeksi suljettu 104.74 USD
Sektori Healthcare
Teollisuus Medical Devices
Vaihto NYSE
Pääomitus 182 208 839 680 USD
Tuotto 12 kuukautta. -4.39 %
1Y
3Y
5Y
10Y
15Y
ABT
21.11.2021 - 28.11.2021

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400

Tarkista sijoitusideasi

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

126.23 USD

P/E ratio

32.6293

Dividend Yield

2.1 %

Kuluva vuosi

+40 109 000 000 USD

Edellinen vuosi

+43 653 000 000 USD

Nykyinen vuosineljännes

+9 964 000 000 USD

Viimeinen vuosineljännes

+10 241 000 000 USD

Kuluva vuosi

+22 134 000 000 USD

Edellinen vuosi

+24 511 000 000 USD

Nykyinen vuosineljännes

+5 544 000 000 USD

Viimeinen vuosineljännes

+5 258 000 000 USD

Avainluvut ABT

1 vuosi
3 vuotta
5 vuotta
10 vuotta
21.11.2021 - 28.11.2021
EBITDA 10 368 000 000 USD
Operating Margin TTM 15.41 %
PE Ratio 32.6293
Return On Assets TTM 6.09 %
PEG Ratio 5.9854
Return On Equity TTM 14.76 %
Wall Street Target Price 126.23 USD
Revenue TTM 40 326 000 640 USD
Book Value 22.31 USD
Revenue Per Share TTM 23.18 USD
Dividend Share 2.12 USD
Quarterly Revenue Growth YOY 2.2 %
Dividend Yield 2.1 %
Gross Profit TTM 24 579 000 000 USD
Earnings Share 3.21 USD
Diluted Eps TTM 3.21 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -6.7 %
Profit Margin 13.96 %

Osinkoanalytiikka ABT

Mestari - 10+ peräkkäistä vuotta osinkojen korotuksia

Osinkojen kasvu 5 vuoden aikana

82 %

Jatkuva kasvu

10 vuotta

Maksusuhde 5 vuoden keskiarvo

57 %

Osinkohistoria ABT

1 vuosi
3 vuotta
5 vuotta
10 vuotta
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 2.2
Ex Dividend Date 12.04.2024
Forward Annual Dividend Yield 2.1 %
Last Split Factor 10000:4798
Payout Ratio 48.29 %
Last Split Date 02.01.2013
Dividend Date 15.05.2024

Osakkeen arvostus ABT

1 vuosi
3 vuotta
5 vuotta
10 vuotta
21.11.2021 - 28.11.2021
Trailing PE 32.6293
Forward PE 23.6407
Enterprise Value Revenue 4.9284
Price Sales TTM 4.7203
Enterprise Value EBITDA 18.7476
Price Book MRQ 4.9044

Talousasiat ABT

1 vuosi
3 vuotta
5 vuotta
10 vuotta
15 vuotta
Tuloksia 2019 Dynamiikka
* Tämän ajanjakson tietoja ei ole vielä julkaistu

Tekniset indikaattorit ABT

52 viikon ajalta

88.8 USD 121.04 USD
50 Day MA 111.26 USD
Shares Short Prior Month 14 481 157
200 Day MA 106.46 USD
Short Ratio 2.74
Shares Short 14 478 910
Short Percent 0.84 %

Omaisuuden arvon muutosten dynamiikka

Osakkeet


MSFT

MSFT

416.56 USD Microsoft Corporation +4.26 (+1.03%)
Yksityiskohtainen analytiikka

ETF-rahastot


S

SX7EEX

14.62 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.21 (+1.34%)
Yksityiskohtainen analytiikka

Metallit


Gold

2356.68 USD Gold +12.53 (+0.53%)
Yksityiskohtainen analytiikka